Found: 64
Select item for more details and to access through your institution.
Selective modulation of ANP-dependent dilatation in the pulmonary vasculature by PDE 5 inhibitors: a novel combination therapy for pulmonary hypertension?
- Published in:
- 2007
- By:
- Publication type:
- Abstract
miR-21/DDAH1 pathway regulates pulmonary vascular responses to hypoxia.
- Published in:
- Biochemical Journal, 2014, v. 462, n. 1, p. 103, doi. 10.1042/BJ20140486
- By:
- Publication type:
- Article
Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Novel and Relevant Mechanistic Pathways.
- Published in:
- Advances in Pulmonary Hypertension, 2020, v. 19, n. 2, p. 42, doi. 10.21693/1933-088X-19.2.42
- By:
- Publication type:
- Article
Metabolomic Insights in Pulmonary Arterial Hypertension.
- Published in:
- Advances in Pulmonary Hypertension, 2018, v. 17, n. 3, p. 103, doi. 10.21693/1933-088X-17.3.103
- By:
- Publication type:
- Article
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00891-1
- By:
- Publication type:
- Article
Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00891-1
- By:
- Publication type:
- Article
Environmental and genetic predictors of human cardiovascular ageing.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40566-6
- By:
- Publication type:
- Article
A Pilot Randomized, Placebo Controlled, Double Blind Phase I Trial of the Novel SIRT1 Activator SRT2104 in Elderly Volunteers.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0051395
- By:
- Publication type:
- Article
Clinical, Ethical and Financial Implications of Incidental Imaging Findings: Experience from a Phase I Trial in Healthy Elderly Volunteers.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0049814
- By:
- Publication type:
- Article
Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 12, p. 1477, doi. 10.1164/rccm.202307-1236OC
- By:
- Publication type:
- Article
Restoration of Foxp3<sup>+</sup> Regulatory T Cells by HDAC-Dependent Epigenetic Modulation Plays a Pivotal Role in Resolving Pulmonary Arterial Hypertension Pathology.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 8, p. 879, doi. 10.1164/rccm.202301-0181OC
- By:
- Publication type:
- Article
Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Immunoglobulin-Driven Complement Activation Regulates Pro-Inflammatory Remodeling in Pulmonary Hypertension.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2020, v. 201, n. 2, p. E1, doi. 10.1164/rccm.201903-0591oc
- By:
- Publication type:
- Article
Apoptosis Signal-Regulating Kinase 1 Inhibition in Pulmonary Hypertension: Too Much to ASK?
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2018, v. 197, n. 3, p. 286, doi. 10.1164/rccm.201709-1814ED
- By:
- Publication type:
- Article
The effects of sitaxentan on sildenafil pharmacokinetics and pharmacodynamics in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 69, n. 1, p. 23, doi. 10.1111/j.1365-2125.2009.03541.x
- By:
- Publication type:
- Article
Pulmoner hipertansiyon tanı ve tanımlar.
- Published in:
- Archives of the Turkish Society of Cardiology / Türk Kardiyoloji Derneği Arşivi, 2014, v. 42, n. Supp 1, p. 108
- By:
- Publication type:
- Article
Pulmonary arterial hypertension and the vasoconstrictive factor: is there still a role for vasodilator testing?
- Published in:
- European Heart Journal, 2003, v. 24, n. 4, p. 297, doi. 10.1016/S0195-668X(02)00753-4
- By:
- Publication type:
- Article
Tipifarnib prevents development of hypoxiainduced pulmonary hypertension.
- Published in:
- Cardiovascular Research, 2017, n. 3, p. 276, doi. 10.1093/cvr/cvw258
- By:
- Publication type:
- Article
Variation in binding affinity of the novel anxiolytic XBD173 for the 18 kDa translocator protein in human brain.
- Published in:
- Synapse, 2011, v. 65, n. 3, p. 257, doi. 10.1002/syn.20884
- By:
- Publication type:
- Article
Intracellular Chloride Channels Regulate Endothelial Metabolic Reprogramming in Pulmonary Arterial Hypertension.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2023, v. 68, n. 1, p. 103, doi. 10.1165/rcmb.2022-0111OC
- By:
- Publication type:
- Article
Two binding sites for [<sup>3</sup>H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2010, v. 30, n. 9, p. 1608, doi. 10.1038/jcbfm.2010.63
- By:
- Publication type:
- Article
A Comparison of the Effects of Mibefradil and Atenolol on Regression of Left Ventricular Hypertrophy in Hypertensive Patients.
- Published in:
- Cardiology, 1998, v. 89, n. 4, p. 263
- By:
- Publication type:
- Article
ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport.
- Published in:
- Cardiovascular Research, 2024, v. 120, n. 7, p. 756, doi. 10.1093/cvr/cvae068
- By:
- Publication type:
- Article
Downregulation of natriuretic peptide C-receptor protein in the hypertrophied ventricle of the aortovenocaval fistula rat.
- Published in:
- Cardiovascular Research, 1997, v. 36, n. 3, p. 363, doi. 10.1016/S0008-6363(97)00192-2
- By:
- Publication type:
- Article
Iron deficiency in systemic sclerosis patients with and without pulmonary hypertension.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Iron deficiency in systemic sclerosis patients with and without pulmonary hypertension.
- Published in:
- Rheumatology, 2014, v. 53, n. 2, p. 285, doi. 10.1093/rheumatology/ket331
- By:
- Publication type:
- Article
Update in Pulmonary Vascular Diseases 2012.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2013, v. 188, n. 1, p. 23, doi. 10.1164/rccm.201303-0470UP
- By:
- Publication type:
- Article
Reduced MicroRNA-150 Is Associated with Poor Survival in Pulmonary Arterial Hypertension.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2013, v. 187, n. 3, p. 294, doi. 10.1164/rccm.201205-0839oc
- By:
- Publication type:
- Article
Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Genetic Association of the Serotonin Transporter in Pulmonary Arterial Hypertension.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2006, v. 173, n. 7, p. 793, doi. 10.1164/rccm.200509-1365OC
- By:
- Publication type:
- Article
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) Study.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2005, v. 171, n. 11, p. 1292, doi. 10.1164/rccm.200410-1411OC
- By:
- Publication type:
- Article
Antiproliferative Effects of Phosphodiesterase Type 5 Inhibition in Human Pulmonary Artery Cells.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2005, v. 172, n. 1, p. 105, doi. 10.1164/rccm.200411-1587OC
- By:
- Publication type:
- Article
Anti-proliferative Effects of Phosphodiesterase Type 5 Inhibition in Human Pulmonary Artery Cells.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2005, v. 172, n. 1, p. 1, doi. 10.1164/rccm.200411-1587oc
- By:
- Publication type:
- Article
Selective or nonselective endothelin receptor blockade in pulmonary arterial hypertension.
- Published in:
- 2004
- By:
- Publication type:
- Editorial
Mendelian Randomization Study With Clinical Follow-Up Links Metabolites to Risk and Severity of Pulmonary Arterial Hypertension.
- Published in:
- Journal of the American Heart Association, 2024, v. 13, n. 6, p. 1, doi. 10.1161/JAHA.123.032256
- By:
- Publication type:
- Article
Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 60, n. 1, p. 107, doi. 10.1111/j.1365-2125.2005.02383.x
- By:
- Publication type:
- Article
The regulation of pulmonary vascular tone.
- Published in:
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 1, p. 127, doi. 10.1046/j.1365-2125.1996.37117.x
- By:
- Publication type:
- Article
Hypoxia‐induced pulmonary hypertension—Utilizing experiments of nature.
- Published in:
- British Journal of Pharmacology, 2021, v. 178, n. 1, p. 121, doi. 10.1111/bph.15144
- By:
- Publication type:
- Article
The application of 'omics' to pulmonary arterial hypertension.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Metabolic pathways associated with right ventricular adaptation to pulmonary hypertension: 3D analysis of cardiac magnetic resonance imaging.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2019, v. 20, n. 6, p. 668, doi. 10.1093/ehjci/jey175
- By:
- Publication type:
- Article
The zinc transporter ZIP12 regulates the pulmonary vascular response to chronic hypoxia.
- Published in:
- Nature, 2015, v. 524, n. 7565, p. 356, doi. 10.1038/nature14620
- By:
- Publication type:
- Article
PTPN1 Deficiency Modulates BMPR2 Signaling and Induces Endothelial Dysfunction in Pulmonary Arterial Hypertension.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 2, p. 316, doi. 10.3390/cells12020316
- By:
- Publication type:
- Article
Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension.
- Published in:
- Human Mutation, 2011, v. 32, n. 12, p. 1385, doi. 10.1002/humu.21605
- By:
- Publication type:
- Article
Expression Quantitative Trait Locus Mapping in Pulmonary Arterial Hypertension.
- Published in:
- Genes, 2020, v. 11, n. 11, p. 1247, doi. 10.3390/genes11111247
- By:
- Publication type:
- Article
An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-04169-z
- By:
- Publication type:
- Article
Author Correction: Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14966-x
- By:
- Publication type:
- Article
Two prospective, multicenter studies for the identification of biomarker signatures for early detection of pulmonary hypertension (PH): The CIPHER and CIPHER‐MRI studies.
- Published in:
- Pulmonary Circulation, 2024, v. 14, n. 2, p. 1, doi. 10.1002/pul2.12386
- By:
- Publication type:
- Article